Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2014
08/21/2014US20140234449 Appetite regulating dietary supplement
08/21/2014US20140234435 Setting of hardenable bone substitute
08/21/2014US20140234418 Method for treating intestinal fibrosis
08/21/2014US20140234414 Novel Dosage Form
08/21/2014US20140234410 Combination products
08/21/2014US20140234405 Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent
08/21/2014US20140234401 Method of treating inflammation using human immunosuppressive protein
08/21/2014US20140234400 Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells
08/21/2014US20140234398 Dissolution of Arterial Plaque
08/21/2014US20140234397 Treatment of klebsiella pneumoniae with liposomally formulated glutathione
08/21/2014US20140234382 Peptide nanoparticles and uses therefor
08/21/2014US20140234362 Defensin-antigen fusion proteins
08/21/2014US20140234341 Acute hepatic insufficiency depressant and method for evaluating drug efficacy thereof
08/21/2014US20140234334 Peptides and related molecules that bind to tall-1
08/21/2014US20140234322 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
08/21/2014US20140234320 Modulators of 4-1bb and immune responses
08/21/2014US20140234319 Treatment of heart failure and related conditions
08/21/2014US20140234318 Tumor specific oligosaccharide epitopes and use thereof
08/21/2014US20140234310 Compositions and methods for treatment of bacterial and mycobacterial infections
08/21/2014US20140234302 Methods and Compositions for Reducing Amyloid Beta Levels
08/21/2014US20140234301 Modulation of PILR to Treat Immune Disorders
08/21/2014US20140234299 Therapies for chronic renal failure using one or more integrin antagonists
08/21/2014US20140234293 Combination Therapy Using Immunoglobulin and C1-Inhibitor
08/21/2014US20140234292 Process for Producing a Plasma Protein-Containing Medicament
08/21/2014US20140234290 Modified factor x polypeptides and uses thereof
08/21/2014US20140234288 Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases
08/21/2014US20140234287 SUMOYLATION OF SERCA2a AND CARDIOVASCULAR DISEASE
08/21/2014US20140234286 Skeletal muscle regeneration promoter
08/21/2014US20140234285 Method for Therapeutic Angiogenesis
08/21/2014US20140234284 Fast-setting alkoxysilane spray foams
08/21/2014US20140234282 Beta-lactam compounds for treating diabetes
08/21/2014US20140234279 Feed additive composition
08/21/2014US20140234278 Compounds for improved viral transduction
08/21/2014US20140234275 Method for treating als via the increased production of factor h
08/21/2014US20140234274 Directed Evolution and In Vitro Panning of Virus Vectors
08/21/2014US20140234271 Compositions for proliferation of cells and related methods
08/21/2014US20140234257 Oncolytic Viruses and Methods for Treating Neoplastic Disorders
08/21/2014US20140234256 Commensal Bacteria As Signal Mediators Within A Mammalian Host
08/21/2014US20140234255 Microdystrophin peptides and methods for treating muscular dystrophy using the same
08/21/2014US20140234253 Combination Treatments For Hepatitis C
08/21/2014US20140234252 Composition and Methods for the Treatment of Degenerative Retinal Conditions
08/21/2014DE112012003995T5 Caspofunginpräparat mit geringem Verunreinigungsgehalt, Verfahren zu seiner Herstellung und seine Verwendung Caspofunginpräparat with low impurity content, process for its preparation and its use
08/21/2014DE10066235C5 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/20/2014EP2767291A2 Treatment of glycogen storage disease type II
08/20/2014EP2767290A1 Amino acid sequences for controlling pathogens
08/20/2014EP2767286A1 Oral pharmaceutical composition for the treatment of inflammatory gastrointestinal diseases
08/20/2014EP2767163A1 Transmucosal administration of drug compositions for treating and preventing disorders in animals
08/20/2014EP2766495A1 Method of diagnosis, prognostic or treatment of neurodegenerative diseases
08/20/2014EP2766478A1 Novel asparaginase and methods for treating diseases associated with asparagine dependence
08/20/2014EP2766477A2 Recombinant human naglu protein and uses thereof
08/20/2014EP2766390A1 Compositions and methods for treating heart failure
08/20/2014EP2766384A1 Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response
08/20/2014EP2766093A1 Use of semaphorin-4d binding molecules for modulation of blood brain barrier permeability
08/20/2014EP2766045A2 Treatment of breast cancer with companion diagnostic
08/20/2014EP2766036A1 Compositions and methods for modulating thrombin generation
08/20/2014EP2766035A1 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy
08/20/2014EP2766034A1 Zymogen activators
08/20/2014EP2766033A2 Antibodies and methods for wnt pathway-related diseases
08/20/2014EP2766032A1 Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions
08/20/2014EP2766031A1 Antimicrobial peptides for treatment of infectious diseases
08/20/2014EP2766030A1 Engineered outer domain (eod) of hv gp120 and mutants thereof
08/20/2014EP2766029A1 Treatment of degenerative joint disease
08/20/2014EP2766028A2 Peptide inhibitors of bace1
08/20/2014EP2765997A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
08/20/2014EP2765864A1 Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
08/19/2014US8809562 Use of metallocene compounds for cancer treatment
08/19/2014US8809510 Method for purification of complement factor H
08/19/2014US8809506 Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders
08/19/2014US8809505 Mutant alpha-synuclein, and methods using same
08/19/2014US8809504 Inhibitor which is deactivatable by a reagent produced by a target cell
08/19/2014US8809499 Fusion protein of human fibroblast growth factor-21 and exendin-4
08/19/2014US8809495 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability
08/19/2014US8809494 Method and compositions for prevention and treatment of malaria infections
08/19/2014US8809320 Benzodiazepine derivatives
08/19/2014US8809296 Apoptosis inducer for cancer cell
08/19/2014US8809290 Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells
08/19/2014US8809287 Compositions and methods for altering Wnt autocrine signaling
08/19/2014US8809282 Method of reducing titers of antibodies specific for a therapeutic agent
08/19/2014US8809281 Small peptides and methods for blocking IGE mediated activation of an immune cell
08/19/2014US8809280 Therapeutic peptides
08/19/2014US8809279 Peptides that are modulators of the protein TRF2 and compositions containing same
08/19/2014US8809278 Cyclic tetrapeptides
08/19/2014US8809277 Dual secured therapeutic peptide delivery system
08/19/2014US8809276 Activator peptides for synthesizing extracellular matrix proteins, and cosmetic compositions including same
08/19/2014US8809275 Peptoids and methods for treating alzheimer's disease
08/19/2014US8809274 Adhesive hemostatic agent based on porcine atelocollagen and method for production thereof
08/19/2014US8809273 Inhibitors of Bruton's tyrosine kinase
08/19/2014US8809272 Use of liposomal Wnt composition to enhance osseointegration
08/19/2014US8809271 Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
08/19/2014US8809270 Method for reducing cardiovascular morbidity and mortality in prediaetic patients and patients with type 2 diabetes
08/19/2014US8809269 Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
08/19/2014US8809268 Combination therapy to combat helminth resistance
08/19/2014US8809267 Antiviral compounds
08/19/2014US8809266 Antiviral compounds
08/19/2014US8809265 Methods for treating HCV
08/19/2014US8809264 Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
08/19/2014US8809263 Anti-infective hydroxy-phenyl-benzoates and methods of use
08/19/2014US8809262 Multimeric forms of antimicrobial peptides
08/19/2014US8809261 Compositions containing delta-9-THC-amino acid esters and process of preparation
08/19/2014US8809260 β-arrestin effectors and compositions and methods of use thereof
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 3163